No definition available.
Acquired clawhand, clubhand, clawfoot and clubfoot
M13_CLAWCLUBHANDFOOT
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
186 |
4. Check minimum number of eventsNone |
186 |
5. Include endpointsNone |
186 |
6. Filter based on genotype QC (FinnGen only) |
186 |
Control definitions (FinnGen only)
- Control exclude
- M13_ARTHROPATHIES
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M21
- Name in latin
- Deformitas [acquisita] manus sive pedis, typus talipes
Similar endpoints
↥List of similar endpoints to
Acquired clawhand, clubhand, clawfoot and clubfoot
based on the number of shared cases.
Similar with more cases:
- Other joint disorders
- Arthropathies
- Diseases of the musculoskeletal system and connective tissue
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1250 | 679 | 569 |
| Only index persons | 1221 | 666 | 555 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 48.01 | 49.30 | 46.45 |
| Only index persons | 47.95 | 49.50 | 46.08 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 186 | 108 | 78 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.03 |
| Median age at first event (years) | 50.62 | 48.81 | 53.13 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 164
- Matched controls
- 1639
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M21.5
ICD-10 Finland
Acquired clawhand, clubhand, clawfoot and clubfoot
+∞
237.1
164
*
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
645.5
50.2
47
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
32.4
41.5
55
25
NHL68
NOMESCO Finland
Tenodesis, shortening or lengthening of tendon of foot
157.9
36.4
37
*
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
23.2
35.5
52
32
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
25.3
34.5
49
27
M19.0
ICD-10 Finland
Primary arthrosis of other joints
48.9
29.4
35
9
NH3EA
NOMESCO Finland
Feet X-ray examination with load
160.3
26.5
27
*
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
24.8
24.2
34
17
NH1EA
NOMESCO Finland
Ankle X-ray examination with load or wrench
+∞
23.5
22
*
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
38.7
23.3
29
9
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
139.5
23.2
24
*
M25.5
ICD-10 Finland
Pain in joint
7.0
22.6
64
137
B01AB05
ATC
enoxaparin; parenteral
6.0
22.4
77
211
L16
ICPC
Ankle symptom/complaint
11.3
21.9
43
50
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
30.4
21.3
28
11
NHL99
NOMESCO Finland
Other operation on muscle or tendon of ankle or foot
226.0
20.0
20
*
NH1FA
NOMESCO Finland
Weight-bearing X-ray of ankle
226.0
20.0
20
*
NHL14
NOMESCO Finland
Shortening or lengthening of achilles tendon
226.0
20.0
20
*
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
53.1
19.8
23
5
WX320
NOMESCO Finland
Spinalanesthesy
6.6
19.3
56
120
NHM10
NOMESCO Finland
Fasciotomy of ankle or foot
113.1
19.0
20
*
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
75.3
18.2
20
*
Q66.0
ICD-10 Finland
Talipes equinovarus
200.7
17.9
18
*
L17
ICPC
Foot/toe symptom/complaint
5.2
17.7
65
183
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
71.0
17.1
19
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
4.2
17.1
97
417
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
+∞
17.0
16
*
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
188.2
16.8
17
*
N03AX12
ATC
gabapentin; oral
6.4
16.8
48
99
SPAT1229
SPAT
Assessment of need for aid
15.1
16.4
27
21
M17.1
ICD-10 Finland
Other primary gonarthrosis
14.4
16.1
27
22
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
+∞
15.9
15
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
22.8
15.6
22
11
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
35.5
15.2
19
6
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
17.6
14.9
23
15
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
+∞
14.8
14
*
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
+∞
14.8
14
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
6.3
14.5
41
82
Z01.8
ICD-10 Finland
Other specified special examinations
4.5
14.0
57
173
N02AJ06
ATC
codeine and paracetamol; systemic
3.8
13.8
76
302
NHG22
NOMESCO Finland
Fusion of subtalar joint
54.6
13.1
15
*
Q66.7
ICD-10 Finland
Pes cavus
+∞
12.7
12
*
TPH04
NOMESCO Finland
Cathetrisation of vein
4.5
12.2
48
138
M16.1
ICD-10 Finland
Other primary coxarthrosis
50.7
12.1
14
*
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
10.9
11.7
22
23
NHL20
NOMESCO Finland
Myotomy or tenotomy of foot
+∞
11.6
11
*
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
128.6
11.6
12
*
M77.4
ICD-10 Finland
Metatarsalgia
9.2
11.6
24
30
WX702
NOMESCO Finland
Supraglottic ventilation device
10.4
11.4
22
24
NH1AD
NOMESCO Finland
Ankle and foot CT
22.0
11.4
16
8
SPAT1153
SPAT
Removal of sutures
3.5
11.3
65
257
N02AX02
ATC
tramadol; systemic, rectal
3.2
11.0
82
391
N02BE01
ATC
paracetamol; systemic, rectal
4.6
10.9
148
1091
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
9.9
10.7
21
24
M79.6
ICD-10 Finland
Pain in limb
3.3
10.6
68
290
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
13.3
10.6
18
15
ZXA00
NOMESCO Finland
Right side
3.7
10.6
52
181
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
117.1
10.5
11
*
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
35.0
10.5
13
*
L15
ICPC
Knee symptom/complaint
4.6
10.5
38
100
N03AX16
ATC
pregabalin; oral
3.9
10.4
48
158
TQW40
NOMESCO Finland
Remowal of suture of skin
7.4
10.2
24
37
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
3.4
10.1
58
227
M20.1
ICD-10 Finland
Hallux valgus (acquired)
18.2
10.1
15
9
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.2
9.8
40
118
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
105.8
9.5
10
*
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
23.3
9.5
13
6
M75.1
ICD-10 Finland
Rotator cuff syndrome
3.6
9.5
47
164
G60.0
ICD-10 Finland
Hereditary motor and sensory neuropathy
+∞
9.5
9
*
M19.2
ICD-10 Finland
Other secondary arthrosis
+∞
9.5
9
*
M01AH05
ATC
etoricoxib; oral
2.8
9.3
103
611
NHL30
NOMESCO Finland
Suture or reinsertion of tendon of foot
39.0
9.1
11
*
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
7.4
9.0
21
32
ZXA05
NOMESCO Finland
Left side
3.5
9.0
45
158
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
4.7
8.9
31
78
M67.0
ICD-10 Finland
Short Achilles tendon (acquired)
52.8
8.8
10
*
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
5.9
8.7
24
46
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.1
8.6
54
223
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
5.7
8.4
24
48
75400
ICD-8 Finland
Clubfoot (congenital), Pes equino-varus adductus
+∞
8.4
8
*
7545B
ICD-9 Finland
Certain congenital musculoskeletal deformities, Varus deformities of feet[TALIPES EQUINOVARUS CONGENITUS]
+∞
8.4
8
*
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
+∞
8.4
8
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
4.3
8.3
31
84
WX110
NOMESCO Finland
Local anesthesy
2.8
8.0
125
875
SAA02
NOMESCO Finland
Basic examination of mouth
2.8
8.0
122
840
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
9.2
8.0
16
19
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.6
8.0
38
127
S92.3
ICD-10 Finland
Fracture of metatarsal bone
8.7
7.8
16
20
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
8.7
7.8
16
20
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
47.2
7.8
9
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
7.7
56
250
WX720
NOMESCO Finland
Own respiration
7.4
7.5
17
25
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
14.3
7.5
12
9
NHK10
NOMESCO Finland
Incision or excision of metatarsal or tarsal bone
83.7
7.5
8
*
L84
ICD-10 Finland
Corns and callosities
10.1
7.4
14
15
M20.2
ICD-10 Finland
Hallux rigidus
+∞
7.3
7
*
M20.5
ICD-10 Finland
Other deformities of toe(s) (acquired)
+∞
7.3
7
*
WX111
NOMESCO Finland
Local infiltration anesthesia
+∞
7.3
7
*
M21.6
ICD-10 Finland
Other acquired deformities of ankle and foot
+∞
7.3
7
*
L28
ICPC
Limited function/disability (L)
4.3
7.3
27
72
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
12.8
7.2
12
10
A02BC05
ATC
esomeprazole; systemic
2.6
7.2
71
375
UJF32
NOMESCO Finland
Coloscopy
3.0
7.2
46
189
G56.0
ICD-10 Finland
Carpal tunnel syndrome
4.1
7.2
28
79
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.2
7.1
40
151
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.8
7.0
19
36
M01AH01
ATC
celecoxib; oral (coxibs)
3.5
6.9
33
110
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
11.6
6.9
12
11
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
6.0
6.8
18
33
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
23.6
6.7
9
*
L88
ICPC
Rheumatoid/seropositive arthritis
23.6
6.7
9
*
WX400
NOMESCO Finland
Inhalation anesthesy
7.4
6.7
15
22
B01AF01
ATC
rivaroxaban; oral
5.4
6.6
19
39
X59
ICD-10 Finland
Exposure to unspecified factor
3.1
6.6
38
146
M01AE03
ATC
ketoprofen; systemic, rectal
2.5
6.6
66
350
WX213
NOMESCO Finland
Lower leg blockade
72.5
6.5
7
*
NHG26
NOMESCO Finland
Fusion between bones of ankle or ankle and foot
72.5
6.5
7
*
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
72.5
6.5
7
*
NHL50
NOMESCO Finland
Tenolysis or tenosynovectomy of foot
72.5
6.5
7
*
NHG20
NOMESCO Finland
Fusion of talocrural joint
72.5
6.5
7
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.2
6.5
19
40
L29
ICPC
Musculoskeletal sympt/complt other
6.2
6.3
16
28
WX704
NOMESCO Finland
Intubation
4.4
6.3
22
56
NHG82
NOMESCO Finland
Fusion of other tarsal joint
+∞
6.3
6
*
WX210
NOMESCO Finland
Plexus blockade of nervus ichiadicus
+∞
6.3
6
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.3
6.3
74
425
WX725
NOMESCO Finland
Noninvasive ventilation
6.0
6.2
16
29
S09
ICPC
Infected finger/toe
13.2
6.2
10
8
H3600, E103
ICD-10 Finland
NA
13.2
6.2
10
8
M02AA07
ATC
piroxicam; topical
2.5
6.1
60
310
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.8
6.1
43
185
L13
ICPC
Hip symptom/complaint
3.8
6.1
25
74
SPAT1234
SPAT
Support of social functional capacity
7.7
6.1
13
18
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
112
603
3.16
13.19
4.9
4.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
95
468
3.11
13.06
8.4
7.4
inr
1.1
1.2
0.18
25
143
(3013826) Glucose [Moles/volume] in Serum or Plasma
131
784
3.27
12.60
5.2
4.9
mmol/l
6.6
6.6
0.04
120
721
(3042936) Bacteria identified in Isolate by Culture
45
165
3.28
9.92
2.9
2.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
62
276
2.87
9.73
1.6
1.6
mg/l
0.6
1.0
1.79
51
210
(3019309) Folate [Moles/volume] in Red Blood Cells
48
191
3.04
9.17
1.5
1.6
nmol/l
1092.6
1193.7
0.29
35
149
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
100
618
2.34
7.46
9.5
8.0
mmol/l
1.2
1.2
0.09
84
547
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
82
481
2.26
6.75
3.5
3.1
ng/l
31.8
39.7
0.31
57
299
(3013707) Erythrocyte sedimentation rate by Westergren method
138
1008
2.43
6.61
5.9
3.2
mm/h
11.8
10.3
0.65
132
927
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
76
438
2.24
6.47
2.8
2.5
u/l
52.9
52.7
0.01
71
407
(42870588) Differential panel, method unspecified - Blood
73
418
2.23
6.28
5.3
5.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
42
190
2.56
6.13
1.8
2.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
33
136
2.73
5.77
1.5
1.3
titre
500.0
317.0
—
8
27
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
22
72
3.33
5.71
5.9
3.7
mmol/l
1.4
1.5
0.02
14
60
(3024561) Albumin [Mass/volume] in Serum or Plasma
85
537
2.07
5.53
8.2
5.1
g/l
35.6
36.3
0.56
80
505
(3019225) pH of Specimen
29
116
2.78
5.35
6.0
5.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
128
947
2.13
5.34
6.2
3.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
180
1606
4.74
5.30
20.5
10.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
86
552
2.04
5.30
2.9
2.2
nmol/l
76.3
74.2
0.27
79
505
(3026008) Bacteria identified in Urine by Culture
64
368
2.13
5.30
3.1
2.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
87
561
2.03
5.29
7.1
6.6
mmol/l
1.2
1.2
0.01
76
524
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
40
189
2.42
5.28
1.3
1.1
u/ml
32.6
1.5
0.78
15
85
(3012516) Albumin [Mass/volume] in Urine
64
370
2.11
5.22
3.9
3.3
mg/l
1400.4
408.0
0.34
37
251
(3023368) Bacteria identified in Blood by Culture
58
325
2.14
5.11
4.1
4.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
36
165
2.47
5.07
5.9
3.7
%
31.1
30.9
0.04
27
114
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
144
1130
2.21
4.95
4.5
3.7
pmol/l
14.7
14.6
0.19
130
1058
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
77
491
1.97
4.71
2.4
1.8
pmol/l
109.4
94.8
1.22
37
270
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
172
1475
3.21
4.62
19.4
11.6
mg/l
19.7
22.8
0.76
154
1105
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
102
719
1.93
4.60
6.7
7.0
umol/l
9.7
10.8
0.93
96
691
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
164
1376
2.62
4.55
5.7
4.3
mu/l
1.8
2.7
0.57
152
1285
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
17
56
3.24
4.36
10.8
17.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
54
316
2.00
4.14
3.5
2.5
umol/l
322.8
9713.2
2.02
48
286
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
51
296
2.00
3.99
2.6
1.8
mg/l
2.5
2.9
0.76
43
253
(3020682) Albumin/Creatinine [Ratio] in Urine
63
395
1.90
3.93
5.1
3.9
mg/mmol
36.2
9.6
0.69
37
265
(4146454)
8
11
7.54
3.90
5.1
2.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
52
307
1.96
3.86
2.8
3.2
ng/l
1454.8
1048.9
0.29
46
263
(3009508) Creatinine [Moles/volume] in Urine
65
416
1.86
3.78
4.1
3.0
mmol/l
8.4
8.0
0.27
55
367
(3013115) Eosinophils [#/volume] in Blood
98
712
1.80
3.76
5.6
5.7
e9/l
0.2
0.2
0.33
88
631
(3006504) Eosinophils/100 leukocytes in Blood
91
647
1.80
3.75
5.8
5.3
%
2.8
2.8
0.15
79
612
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
37
195
2.12
3.73
1.4
1.2
iu/ml
19.9
13.5
0.36
13
69
(3021960) Folate [Moles/volume] in Serum or Plasma
48
279
1.97
3.72
1.6
1.4
nmol/l
19.6
20.7
0.24
42
242
(3017732) Neutrophils [#/volume] in Blood
21
86
2.63
3.70
2.0
1.9
e9/l
4.1
4.1
0.00
15
79
(3022313) Gas panel - Capillary blood
16
57
2.98
3.62
6.8
4.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
91
652
1.77
3.62
6.0
5.5
%
8.4
8.4
0.03
79
623
(3022096) Basophils/100 leukocytes in Blood
88
628
1.76
3.52
6.0
5.3
%
0.7
0.7
0.28
77
595
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
28
135
2.26
3.50
1.7
1.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
92
666
1.75
3.49
6.0
5.0
%
58.5
57.2
0.52
82
637
(3013512) EKG study
55
344
1.85
3.39
4.2
3.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
30
151
2.18
3.39
3.1
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
44
256
1.94
3.38
1.3
1.7
pmol/l
449.9
460.0
0.08
36
222
(36660697) Celiac disease serology panel - Serum
26
124
2.27
3.33
1.1
1.1
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
92
673
1.73
3.32
5.9
5.2
%
27.2
28.0
0.34
82
644
(3012095) Magnesium [Moles/volume] in Serum or Plasma
39
220
1.98
3.27
3.2
4.1
mmol/l
0.8
0.8
0.03
34
213
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
135
1103
1.82
3.26
3.9
2.9
u/l
39.9
44.2
0.53
126
1058
(3019060) Gas panel - Arterial blood
18
73
2.62
3.24
9.4
11.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
52
324
1.84
3.23
1.3
1.2
u/ml
1.5
2.4
0.25
11
93
(3044640) Blood type and Crossmatch panel - Blood
62
408
1.78
3.22
2.5
2.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
50
2.95
3.16
2.2
2.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
12
6.01
3.05
1.6
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
21
4.45
3.03
4.9
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
30
159
2.06
2.97
3.2
2.1
%
25.5
23.5
0.34
22
135
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
14
52
2.83
2.96
1.0
1.0
—
12.4
—
0
7
(3019897) Erythrocyte distribution width [Ratio] by Automated count
8
17
4.87
2.95
2.0
2.2
%
12.9
12.8
—
8
17
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
26
133
2.11
2.82
1.7
1.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
33
188
1.92
2.68
1.4
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
12
44
2.85
2.60
1.6
1.8
nmol/l
34.7
38.4
0.25
12
44
(3003396) Base excess in Arterial blood by calculation
25
131
2.05
2.55
8.5
11.7
mmol/l
2.8
1.5
0.54
16
102
(3019198) Lymphocytes [#/volume] in Blood
92
707
1.60
2.53
5.7
5.3
e9/l
1.9
1.9
0.26
81
631
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
69
499
1.61
2.42
5.7
3.1
u/l
26.5
30.0
1.13
62
477
(3001604) Monocytes [#/volume] in Blood
89
684
1.58
2.42
5.9
5.3
e9/l
0.6
0.6
0.24
80
599
(3004789) Transferrin [Mass/volume] in Serum or Plasma
31
179
1.88
2.42
3.0
2.0
g/l
2.2
2.3
0.60
26
166
(3006315) Basophils [#/volume] in Blood
89
685
1.57
2.39
5.9
5.3
e9/l
0.0
0.0
0.18
82
600
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
22
3.75
2.39
6.3
1.9
—
—
—
0
0
(4010399)
19
93
2.16
2.31
1.4
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
13
4.73
2.29
1.0
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
13
4.73
2.29
1.8
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
40
255
1.72
2.26
2.9
3.9
ng/l
9.1
341.5
2.10
27
181
(3038026) Centromere Ab [Units/volume] in Serum
5
9
5.67
2.22
1.6
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
24
3.43
2.20
4.9
2.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
14
4.39
2.17
1.2
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
15
69
2.28
2.11
1.1
3.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
27
156
1.85
2.10
1.1
1.7
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
20
3.59
2.07
1.1
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
20
3.59
2.07
1.1
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
50
2.50
2.07
2.0
2.1
—
—
—
0
0
(44790048)
6
15
4.10
2.05
1.2
1.6
—
—
—
0
0
(44790047)
6
15
4.10
2.05
1.2
1.6
—
—
—
0
0
(44790049)
6
15
4.10
2.05
1.2
1.6
—
—
—
0
0
(44806118)
6
15
4.10
2.05
1.2
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
102
830
1.51
2.02
8.2
9.5
e9/l
4.3
4.0
0.45
88
725
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
33
2.81
1.96
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
33
2.81
1.96
1.8
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
155
1392
1.68
1.88
7.5
5.0
mmol/mol
40.7
39.1
0.92
150
1313
(3044889) 12 lead EKG panel
118
1000
1.49
1.85
3.8
3.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
7
23
3.12
1.81
2.7
1.8
g/l
130.6
132.1
—
7
16
(3005570) Glucose [Moles/volume] in Urine
6
18
3.41
1.76
1.8
1.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
18
3.41
1.76
1.2
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
11
48
2.37
1.74
1.1
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
24
2.99
1.74
1.4
1.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
10
42
2.46
1.71
1.2
1.2
g/l
1.3
1.2
—
10
42
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
10
42
2.46
1.71
1.2
1.3
g/l
0.3
0.2
—
10
42
(3007164) IgA [Mass/volume] in Serum or Plasma
41
285
1.56
1.65
1.3
1.3
g/l
2.3
2.3
0.01
28
186
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
14
3.64
1.62
2.2
2.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
162
1489
1.68
1.58
4.5
3.6
mmol/l
1.3
1.3
0.17
153
1400
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
42
298
1.53
1.54
2.6
2.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
44
0.00
1.53
0.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
15
3.39
1.53
1.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
15
3.39
1.53
1.2
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
123
1071
1.44
1.53
2.8
3.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
27
2.65
1.53
1.7
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
21
2.92
1.52
1.2
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
83
679
1.40
1.45
3.6
2.9
estimate
0.0
0.0
0.00
16
122
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
22
2.78
1.44
1.0
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
167
1555
1.72
1.44
5.1
4.0
mmol/l
4.6
4.8
1.26
158
1467
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
12
61
2.03
1.36
1.2
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
160
1480
1.58
1.35
4.7
4.0
mmol/l
5.9
5.8
0.16
149
1376
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
16
91
1.83
1.34
1.9
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
18
2.82
1.29
1.0
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
80
664
1.36
1.24
3.4
2.5
ug/l
113.6
112.2
0.02
75
623
(1761868) Lipid panel - Serum or Plasma
53
664
0.72
1.22
3.2
2.6
—
—
—
0
0
(1002224) Polysomnography panel
14
79
1.84
1.20
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
38
2.15
1.20
1.0
1.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
31
2.31
1.11
1.3
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
25
352
0.67
1.09
5.4
6.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
24
163
1.54
1.08
1.5
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
167
1579
1.56
1.04
5.5
4.4
mmol/l
2.7
2.9
1.55
156
1482
(3005322) IgE [Units/volume] in Serum or Plasma
15
91
1.71
1.04
1.4
1.3
u/ml
60.6
162.8
2.48
15
80
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
34
2.10
1.04
1.3
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
10
53
1.94
1.03
2.7
2.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
164
1550
1.49
0.96
5.2
3.9
mmol/l
1.4
1.4
0.17
155
1456
(3041096) Erythrocytes [Presence] in Urine by Automated
51
409
1.34
0.96
3.3
2.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
40
309
1.38
0.95
3.7
3.0
kg/l
1.0
1.0
—
6
36
(40760888) Immunoglobulin light chains.free panel - Serum
6
27
2.26
0.94
1.0
6.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
66
551
1.31
0.94
4.0
2.9
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
6
28
2.18
0.92
1.0
3.0
mmol/l
1.2
1.2
—
6
28
(3052851) Hemolysis interference index of Serum or Plasma
6
29
2.10
0.90
3.0
3.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
8
42
1.94
0.90
2.0
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
48
386
1.33
0.89
3.7
3.9
ph
7.4
7.4
—
10
69
(3044290) Cell count panel - Cerebral spinal fluid
6
30
2.03
0.87
1.2
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
30
2.03
0.87
1.2
1.8
—
—
—
0
0
(3012544) pH of Venous blood
18
121
1.54
0.86
2.0
3.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
45
1.81
0.85
2.1
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
80
694
1.27
0.83
3.7
2.9
estimate
0.0
0.0
0.00
16
113
(3021601) Nitrite [Presence] in Urine by Test strip
79
687
1.26
0.80
4.8
4.1
estimate
0.0
0.0
0.00
17
119
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
24
0.00
0.80
0.0
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
48
392
1.30
0.79
2.0
1.7
mmol/l
1.5
1.4
0.29
41
328
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
25
0.00
0.79
0.0
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
0
27
0.00
0.78
0.0
3.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
53
440
1.29
0.78
2.2
3.8
mmol/l
2.3
2.4
0.56
44
397
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
134
0.58
0.76
1.8
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
38
1.87
0.74
2.7
3.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
5
25
2.03
0.73
1.0
1.4
—
41.9
—
0
5
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
9
57
1.61
0.72
1.8
3.1
%
28.3
50.5
—
9
57
(3049717) Cytology report of Urine Cyto stain
7
41
1.73
0.70
2.6
2.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
41
1.73
0.70
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
13
190
0.66
0.69
2.1
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
20
145
1.43
0.69
7.2
5.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
27
1.87
0.69
1.2
2.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
28
1.81
0.66
1.0
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
44
1.61
0.66
1.0
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
15
210
0.69
0.65
2.1
2.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
30
236
1.32
0.65
1.6
1.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
29
1.74
0.64
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
29
1.74
0.64
1.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
15
105
1.47
0.62
4.7
3.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
43
358
1.26
0.62
4.6
3.1
estimate
0.0
0.0
0.50
14
117
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
80
1.53
0.61
1.4
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
20
0.00
0.60
0.0
3.2
—
4.2
—
0
20
(3035285) Chloride [Moles/volume] in Venous blood
0
20
0.00
0.60
0.0
3.1
—
104.6
—
0
20
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
20
0.00
0.60
0.0
3.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
42
351
1.25
0.59
3.6
3.9
%
20.2
20.3
0.02
17
153
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
51
436
1.23
0.58
5.0
4.2
ug/l
1.5
2.1
1.02
46
399
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
6
36
1.69
0.57
1.8
1.3
pmol/l
179.5
81.0
—
6
36
(3034770) Mitochondria Ab [Titer] in Serum
6
36
1.69
0.57
1.0
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
37
1.64
0.56
1.3
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
40
1.52
0.52
1.7
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
21
167
1.29
0.44
2.9
1.6
—
—
—
0
0
(3000492) Spirometry study
19
150
1.30
0.42
1.3
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
15
0.00
0.41
0.0
1.9
—
13.7
—
0
15
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
7.1
—
0.6
—
0
15
(3002256) Pathology report gross observation
22
178
1.27
0.41
1.5
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
34
1.48
0.40
1.0
1.4
—
—
—
0
0
(4268621)
0
18
0.00
0.40
0.0
2.4
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
19.8
—
1641.5
—
0
18
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
13.9
—
887.4
—
0
18
(3025941) Bacteria identified in Stool by Culture
11
80
1.40
0.39
1.1
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
66
599
1.16
0.39
2.2
2.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
36
1.40
0.38
1.8
1.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
71
1.28
0.36
1.7
1.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
51
456
1.16
0.36
4.5
2.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
33
285
1.19
0.35
1.6
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
57
626
0.87
0.34
11.2
7.6
e9/l
0.0
0.0
0.62
52
502
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
6
87
0.68
0.34
2.0
1.9
mg/l
8.0
3.0
—
6
62
(3008898) HLA-B27 [Presence]
6
47
1.29
0.32
1.2
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
12
93
1.31
0.30
6.8
3.1
mmol/l
1.2
1.2
0.27
12
84
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
106
0.74
0.30
1.4
1.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
15
122
1.25
0.28
1.2
1.2
iu/ml
117.5
147.2
—
6
55
(3003694) ABO and Rh group [Type] in Blood
47
427
1.13
0.27
1.3
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
13
160
0.80
0.27
1.6
2.0
—
—
—
0
0
(4035726)
15
123
1.24
0.26
1.3
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
148
1441
1.13
0.24
13.7
10.5
ml/min/173m2
84.2
86.0
0.37
117
1190
(3015183) Erythrocyte sedimentation rate
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
4.9
—
116.6
—
0
11
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
485.3
—
0
6
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
247.8
—
0
5
(3004775) Volume in Urine collected for unspecified duration
0
11
0.00
0.21
0.0
1.8
—
538.0
—
0
5
(3035933) Granulocytes/100 leukocytes in Blood
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
10.1
—
0
10
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
10
0.00
0.21
0.0
3.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
3.7
—
0
5
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
3.5
—
1008.5
—
0
13
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.9
—
18.1
—
0
14
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
16
186
0.85
0.20
1.9
2.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
19
217
0.86
0.20
2.4
2.5
e6/l
1.1
1.0
—
10
112
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
14
118
1.20
0.19
3.2
3.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
51
1.18
0.19
1.7
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
18
157
1.16
0.18
1.3
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
31
339
0.90
0.17
3.9
4.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
62
1.13
0.17
1.3
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
25
225
1.13
0.17
1.4
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
29
264
1.12
0.17
1.5
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
24
265
0.89
0.16
3.0
2.4
ug/l
0.8
0.8
0.05
11
156
(3022621) pH of Urine by Test strip
9
78
1.16
0.15
2.0
2.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
19
172
1.12
0.12
1.3
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
33
349
0.93
0.09
4.3
2.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
56
1.07
0.09
1.5
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
33
348
0.94
0.08
4.3
2.7
e6/l
0.1
0.4
1.93
27
245
(3050129) First trimester maternal screen panel - Serum or Plasma
6
58
1.04
0.08
1.2
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
19
205
0.92
0.08
2.8
2.6
e6/l
3.0
2.0
0.22
11
100
(3011397) Hemoglobin [Presence] in Urine by Test strip
28
296
0.94
0.08
4.1
3.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
82
0.85
0.07
1.1
1.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
9
103
0.87
0.06
4.6
7.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
32
307
1.05
0.05
1.7
2.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
14
134
1.05
0.00
4.8
4.5
ug/l
2.5
11.0
—
9
118
(3009542) Hematocrit [Volume Fraction] of Blood
147
1464
1.02
0.00
19.4
11.9
%
41.1
40.8
0.23
98
1156
(3021879) Hepatitis B virus core Ab [Presence] in Serum
10
104
0.96
0.00
1.3
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
11
111
0.99
0.00
4.0
2.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
39
389
1.00
0.00
4.2
2.7
e6/l
18.1
45.3
0.95
33
285
(3018095) Leukocytes [#/volume] in Urine
45
449
1.00
0.00
4.5
3.2
e6/l
13.8
174.2
1.00
35
309
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
1266.3
—
0
8
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44813793)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
9
89
1.01
0.00
1.0
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
87
0.92
0.00
1.1
1.7
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
53
0.94
0.00
1.0
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
7
0.00
0.00
0.0
4.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
11
110
1.00
0.00
2.0
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
7
0.00
0.00
0.0
4.1
—
18.1
—
0
7
(3029075) Extractable nuclear Ab panel - Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000012) Reticulocyte production index
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
18.5
—
0
6
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_CLAWCLUBHANDFOOT and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have M13_CLAWCLUBHANDFOOT.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: M13_CLAWCLUBHANDFOOT – Acquired clawhand, clubhand, clawfoot and clubfoot
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data